SCHEMBL7334879

SCHEMBL7334879

CCCCCCc1ccc2cc(C(=O)OC)ccc2c1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP4A11 Q02928 3/20 0.54
▸ CYP4F2 P78329 2/20 0.54
▸ MDH1 P40925 2/20 0.53
▸ DHODH Q02127 1/20 0.52
▸ MAPT P10636 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ PPARG P37231 1/20 0.50
▸ PPARA Q07869 1/20 0.50
▸ MGLL Q99685 1/20 0.49
▸ HAO1 Q9UJM8 1/20 0.49
▸ RARB P10826 4/20 0.49
▸ THRA P10827 1/20 0.49
▸ THRB P10828 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ RARA P10276 1/20 0.49
▸ MTOR P42345 1/20 0.49
▸ KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11030754 1.00 CYP4A11 (0.54) CYP4A11CYP4F2MDH1DHODHMAPT
SCHEMBL2402292 1.00 CYP4A11 (0.54) CYP4A11CYP4F2MDH1DHODHMAPT
SCHEMBL181229 1.00 CYP4A11 (0.54) CYP4A11CYP4F2MDH1DHODHMAPT
SCHEMBL11028757 1.00 CYP4A11 (0.54) CYP4A11CYP4F2MDH1DHODHMAPT
SCHEMBL7338653 1.00 CYP4A11 (0.54) CYP4A11CYP4F2MDH1DHODHMAPT
SCHEMBL20178553 0.94 CYP4A11 (0.54) CYP4A11CYP4F2MDH1DHODHMAPT
SCHEMBL6069166 0.85 CYP4A11 (0.73) CYP4A11CYP4F2MAPTSMN1; SMN2HAO1
SCHEMBL14660877 0.85 CYP4A11 (0.73) CYP4A11CYP4F2MAPTSMN1; SMN2HAO1
SCHEMBL12814607 0.85 CYP4A11 (0.73) CYP4A11CYP4F2MAPTSMN1; SMN2HAO1
SCHEMBL10986414 0.85 CYP4A11 (0.73) CYP4A11CYP4F2MAPTSMN1; SMN2HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788511-B1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO (JP) 2002-12-11 — — EP disclosed
US-6265536-B1 MICROBIOCIDE AND FUNGICIDE WHICH IS INHIBITOR OF BETA-1,3-GLUCAN SYNTHASE; TREATMENT OF PNEUMOCYSTIS CARINII INFECTION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-07-24 — — US disclosed
US-6107458-A FUNGICIDE WHICH IS BETA-1,3-GLYCAN SYNTHASE INHIBITOR; FOR PROPHYLAXIS AND TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS LIKE PNEUMONIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-22 — — US disclosed
EP-0788511-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-13 — — EP disclosed
WO-1996011210-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-18 — — WO disclosed
Send feedback